Trials / Sponsors / Inozyme Pharma
Inozyme Pharma
Industry · 11 registered clinical trials — 4 currently recruiting.
| Status | Trial | Phase | Started |
|---|---|---|---|
| Recruiting | ENERGY 2: Evaluation of the Efficacy and Safety of INZ-701 in Infants With ENPP1 Deficiency Ectonucleotide Pyrophosphatase/phosphodiesterase1 Deficiency, Autosomal Recessive Hypophosphatemic Rickets, Generalized Arterial Calcification of Infancy 1 | Phase 3 | 2025-03-26 |
| Withdrawn | The ENABLE Study: Safety and Efficacy Study of INZ-701 in Patients With ENPP1 Deficiency Ectonucleotide Pyrophosphatase/phosphodiesterase1 Deficiency, Autosomal Recessive Hypophosphatemic Rickets, Generalized Arterial Calcification of Infancy 1 | Phase 2 | 2025-01-31 |
| Recruiting | PROPEL - A Prospective Observational Patient Registry to Evaluate ENPP1 and ABCC6 Deficiency Ectonucleotide Pyrophosphatase/Phosphodiesterase 1 Deficiency, ATP-Binding Cassette Subfamily C Member 6 Deficiency | — | 2024-07-25 |
| Recruiting | ADAPT Study: Long-term Safety Study of INZ-701 in Patients With ENPP1 Deficiency and ABCC6 Deficiency Gene Mutations, Pseudoxanthoma Elasticum, Arterial Calcification | Phase 2 | 2024-06-19 |
| Completed | The SEAPORT 1 Study: Evaluation of the Safety and Tolerability of INZ-701 in Adults With End-Stage Kidney Dise Calciphylaxis | Phase 1 | 2024-02-12 |
| Active Not Recruiting | The ENERGY 3 Study: Evaluation of Efficacy and Safety of INZ-701 in Children With ENPP1 Deficiency Ectonucleotide Pyrophosphatase/Phosphodiesterase1 Deficiency, Autosomal Recessive Hypophosphatemic Rickets, Generalized Arterial Calcification of Infancy | Phase 3 | 2023-11-05 |
| Recruiting | The ENERGY Study: Evaluation of Safety and Tolerability of INZ-701 in Infants With ENPP1 Deficiency or ABCC6 D Ectonucleotide Pyrophosphatase/phosphodiesterase1 Deficiency, Autosomal Recessive Hypophosphatemic Rickets, Generalized Arterial Calcification of Infancy | Phase 1 | 2023-06-25 |
| Completed | Natural History Study of ENPP1 Deficiency and the Early-onset Form of ABCC6 Deficiency Ectonucleotide Pyrophosphatase/phosphodiesterase1 Deficiency, ATP-Binding Cassette Subfamily C Member 6 Deficiency, Generalized Arterial Calcification of Infancy | — | 2022-04-27 |
| Completed | Evaluation of Safety, Tolerability, and Efficacy of INZ-701 in Adults With ABCC6 Deficiency Causing PXE ATP-Binding Cassette Subfamily C Member 6 Deficiency, Pseudoxanthoma Elasticum, Generalized Arterial Calcification of Infancy | Phase 1 / Phase 2 | 2022-04-11 |
| Completed | Evaluation of Safety, Tolerability, and Efficacy of INZ-701 in Adults With ENPP1 Deficiency Ectonucleotide Pyrophosphatase/phosphodiesterase1 Deficiency, Autosomal Recessive Hypophosphatemic Rickets, Generalized Arterial Calcification of Infancy | Phase 1 / Phase 2 | 2021-11-21 |
| Completed | Understanding the Spectrum of ENPP1 Deficiency and Acute ABCC6 Deficiency Generalized Arterial Calcification in Infancy, Autosomal Recessive Hypophosphatemic Rickets Type 2 | — | 2020-05-06 |